期刊文献+

冠心病患者血清护骨素与炎症因子水平的相关性及临床意义 被引量:1

下载PDF
导出
摘要 护骨素(osteoprotegerin,0PG),亦称骨保护素或骨保护蛋白,属于肿瘤坏死因子(tumor necrosis factor,TNF)受体家族成员,它是一种重要的血管调节因子,在血管疾病的发生、发展中起重要的调节作用,与动脉粥样硬化关系密切。研究表明,血清OPG水平不仅与冠心病的存在显著相关,而且其水平的增高与冠心病的病死率显著相关,OPG可以作为冠心病病死率的独立预测因子。
作者 唐玉玲
出处 《临床荟萃》 CAS 2012年第13期1149-1150,共2页 Clinical Focus
  • 相关文献

参考文献8

  • 1Blázquez-Medela AM,López-Novoa JM,Martínez-Salgado C. Osteoprotegerin and diabetes-associated pathologies[J].Current Molecular Medicine,2011,(05):401-416.
  • 2Jono S,Lkari Y,Shioi A. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease[J].Circulation,2002,(01):192-194.
  • 3Mangan SH,van Campenhout A,Rush C. Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2[J].Cardiovascular Research,2007,(03):494-505.
  • 4Afify MF,Mohamed GB,E1-Maboud MA. Serum levels of ghrelin,tumor necrosis factor-alpha and interleukin-6 in infants and children with congenital heart disease[J].Journal of Tropical Pediatrics,2009,(06):388-392.
  • 5Kiechl S,Schett G,Wenning G. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease[J].Circulation,2004,(18):2175-2180.doi:10.1161/01.CIR.0000127957.43874.BB.
  • 6Kim HH,Shin HS,Kwak HJ. RANKL regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway[J].Federation of America Societies for Experimental Biology Journal,2003,(14):2163-2165.
  • 7Bucay N,Sarosi I,Dunstan CR. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification[J].Genes and Development,1998,(09):1260-1208.
  • 8Basaran Y,Basaran MM,Babacan KF. Serum tumor necrosis factor levels in acute myocardial infarction and unstable angina pectoris[J].Angiology,1993,(04):332-337.

同被引文献16

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部